These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting. Stinissen P, Raus J. Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096 [Abstract] [Full Text] [Related]
3. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Stinissen P, Raus J, Zhang J. Crit Rev Immunol; 1997 Mar; 17(1):33-75. PubMed ID: 9034723 [Abstract] [Full Text] [Related]
4. Multiple sclerosis: an altered immune response or an altered stress response? van Noort JM. J Mol Med (Berl); 1996 Jun; 74(6):285-96. PubMed ID: 8862510 [Abstract] [Full Text] [Related]
5. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies. Martin R. J Neural Transm Suppl; 1997 Jun; 49():53-67. PubMed ID: 9266414 [Abstract] [Full Text] [Related]
6. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis. Stinissen P, Medaer R, Raus J. Mult Scler; 1998 Jun; 4(3):203-11. PubMed ID: 9762675 [Abstract] [Full Text] [Related]
7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L. Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182 [Abstract] [Full Text] [Related]
10. Immunopathogenesis of multiple sclerosis: concepts and controversies. Holmøy T. Acta Neurol Scand Suppl; 2007 Nov; 187():39-45. PubMed ID: 17419827 [Abstract] [Full Text] [Related]
11. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Mars LT, Saikali P, Liblau RS, Arbour N. Biochim Biophys Acta; 2011 Feb; 1812(2):151-61. PubMed ID: 20637863 [Abstract] [Full Text] [Related]
12. The role of dendritic cells in CNS autoimmunity. Zozulya AL, Clarkson BD, Ortler S, Fabry Z, Wiendl H. J Mol Med (Berl); 2010 Jun; 88(6):535-44. PubMed ID: 20217033 [Abstract] [Full Text] [Related]
13. Deleterious versus protective autoimmunity in multiple sclerosis. Kostic M, Stojanovic I, Marjanovic G, Zivkovic N, Cvetanovic A. Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389 [Abstract] [Full Text] [Related]
14. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Hohlfeld R, Meinl E, Weber F, Zipp F, Schmidt S, Sotgiu S, Goebels N, Voltz R, Spuler S, Iglesias A. Neurology; 1995 Jun; 45(6 Suppl 6):S33-8. PubMed ID: 7783909 [Abstract] [Full Text] [Related]
15. Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood. Yadav SK, Boppana S, Ito N, Mindur JE, Mathay MT, Patel A, Dhib-Jalbut S, Ito K. Proc Natl Acad Sci U S A; 2017 Oct 31; 114(44):E9318-E9327. PubMed ID: 29078267 [Abstract] [Full Text] [Related]
16. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA. Science; 1993 Feb 26; 259(5099):1321-4. PubMed ID: 7680493 [Abstract] [Full Text] [Related]